Skip to content

REGENEREX PHARMA, INC

RGPX

CIK 0001357878

← back to feed
Revenue (TTM)
$2.05K
−31.9% YoY Q2 Nov 2025
Net Income (TTM)
−$2.32M
+28.7% YoY Q2 Nov 2025
EPS Diluted (TTM)
—
Q2 Nov 2025
Gross Margin
70.7%
Q2 Nov 2025
Operating Margin
-97,139.4%
Q2 Nov 2025
Net Margin
-113,308.6%
Q2 Nov 2025
Free Cash Flow (TTM)
—
Q2 Nov 2025
Cash
$11.66K
Q2 Nov 2025
Total Debt
$184.23K
Q2 Nov 2025
Shares Outstanding
282.37M sh
Q2 Nov 2025

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings